Orphan Drug Credit
Contents
Unraveling the Orphan Drug Credit: Incentives for Rare Disease Treatments
Understanding the Orphan Drug Credit
Explore the intricacies of the orphan drug credit, a federal tax incentive aimed at spurring the development of medications for rare diseases. Delve into its purpose, benefits, and impact on pharmaceutical innovation.
Deciphering the Orphan Drug Credit Mechanism
Uncover the mechanics of the orphan drug credit, including its eligibility criteria and the process for claiming the credit. Learn how pharmaceutical companies leverage this incentive to offset developmental costs and bring treatments to market for underserved patient populations.
Tracing the History of the Orphan Drug Credit
Trace the evolution of the orphan drug credit from its inception with the Orphan Drug Act of 1983 to recent modifications under the Trump administration. Understand the rationale behind the credit's creation and subsequent changes, and explore its role in advancing rare disease therapies.